Skip to main content
Covid-19 second wave in Mumbai, India.
War in Gaza:: find out how we're responding
Learn more
We fill gaps in India’s health system and provide specific medical care to neglected people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address specific healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Key activities

Our activities in 2022 in India

Data and information from the International Activity Report 2022.

MSF in India in 2022 In India, Médecins Sans Frontières (MSF) continued to provide treatment for patients living with drug-resistant tuberculosis (DR-TB) and HIV, and medical and psychological care for people affected by conflict and violence.
India IAR map 2022

In the capital, New Delhi, we run a clinic for victims of sexual and gender-based violence, offering round-the-clock care. In December, we organised a national-level symposium calling for better access to medical and psychological care for victims.

Throughout the year, we provided mental health and psychosocial support to people affected by the conflict in Kashmir, and ran mobile clinics offering basic healthcare to communities in remote areas of Chhattisgarh.

In Mumbai, MSF’s clinic focuses on treating complex cases of DR-TB, including extensively drug-resistant forms of the disease, with innovative drug combinations. For children under five, we implement all-oral regimens, thereby avoiding the need for painful injections.

In addition, we are working with the National Tuberculosis Elimination Programme and Municipal Corporation of Greater Mumbai to reduce the high TB incidence and death rates in the area. Our team co-manages a DR-TB centre in a public hospital, and we support diagnosis, treatment, counselling, health promotion and follow-up in general healthcare facilities.

In 2022, we also continued treating patients enrolled in the endTB clinical trial, with the aim of generating more evidence for shorter, more tolerable, injection-free treatments for multidrug-resistant TB.

Our project in Manipur implements a person-centred care approach for people living with HIV, TB, DR-TB and hepatitis C. We transferred many of our stable HIV patients to Ministry of Health facilities, enabling us to focus on those with co-infections and complications. We also run a one-stop care centre offering comprehensive services for intravenous drug users.

In one of India’s poorest states, Bihar, we provide both lifesaving and palliative care to patients living with advanced HIV.

Our toll-free telemedicine helpline supports diabetes patients to manage their condition. India has the second-highest burden of diabetes globally, and the prevention and management of the disease, as well as its associated complications, remain a huge challenge.

 

In 2022
Kala azar-HIV co-infection in Bihar, Animated explainer | ENG
video

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

 
MSF TB Treatment in Mumbai, India
India

At EU-India Summit, India must defend its pharmacy of the developing world

Press Release 29 Mar 2016
 
PCV Vaccination Campaign in Yida Camp
Access to medicines

MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India to increase access to more affordable versions

Crisis Update 11 Mar 2016
 
Hepatitis C in Mumbai
India

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

Project Update 26 Feb 2016
 
India

At African Union – India meeting, leaders should work together to protect access to affordable medicines

Press Release 26 Oct 2015
 
Incredible India elephant graphic
Access to medicines

MSF urges India to protect affordable medicines for millions

Press Release 28 Sep 2015
 
My Life With HIV: Carmen slideshow pictures
Access to medicines

Why MSF needs India to remain open for business

Report 1 Jul 2015
 
Photo Story

Gallery: Chhattisgarh, India: Walking that extra mile

30 Jun 2015
Photo Story
 
India

Access Campaign: MSF launches global campaign urging India to protect access to affordable medicines

Campaign 11 Jun 2015
 
Journal article

MSF calls for community management of acute malnutrition after new evidence shows high cure rates

7 Apr 2015
Journal article
 
India

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

Press Release 19 Mar 2015
 
Kala Azar in Bihar, India
Kala azar

Increased access to diagnosis and treatment of HIV-VL co-infection is imperative for eliminating kala azar

Press Release 1 Dec 2014
 
Kala Azar in Bihar
India

MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State

Press Release 17 Nov 2014

Contact us

Treating kala azar-HIV co-infection in Bihar, India